The Cancer Registry of Norway conducts several research studies focusing on how the use of different medications affects the risk of cancer in the population.
Medications can affect cancer risk; menopausal hormone therapy can for instance influence the risk of breast and ovarian cancer. The aim of the project is to study associations between medication use and the risk of cancer and prognosis after a cancer diagnosis.
Sun exposure is the most important risk factor of cutaneous melanoma, but several studies have suggested that some prescripted drugs also may play a part. This project aims to investigaste if prescripted drugs influence the risk of, and death due to cutaneous melanoma and provide better and more targeted prevention of cutaneous melanoma through the identification of high-risk persons.